Pay in 4 interest-free payments of $6.61 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
The enrolled patients suffered from peripheral mono- and polyneuropathies of various origins including entrapment, traumatic, toxic/alcoholic, diabetic, metabolic, idiopathic, vascular or infective aetiology
Structure raised $748 million in financing in 2025 to fund the aleniglipron programme and its broader oral metabolic portfolio
Other medications Prescription options outside the GLP-1 family can also help with weight management, offering alternatives for different health goals or preferences
Short, thin needle into the deltoid or glute
US$ 26.03
US$ 26.24
US$ 24.74
US$ 20.83
US$ 20.59
